Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2011

Purpose This study aimed to report nationwide cancer statistics in Korea, including incidence, mortality, survival, and prevalence, and their trends. Materials and Methods Incidence data from 1993 to 2011 were obtained from the Korea National Cancer Incidence Database, and vital status was followed through December 31, 2012. Mortality data from 1983 to 2011 were obtained from Statistics Korea. Crude and age-standardized rates for incidence, mortality, and prevalence, and relative survival were calculated. Results A total of 218,017 cancer cases and 71,579 cancer deaths were reported to have occurred in 2011, and there were 1,097,253 prevalent cases identified in Korea as of January 1, 2012. Over the past 13 years (1999-2011), overall incidence rates have increased by 3.4% per year. The incidence rates of liver and cervical cancers have decreased, while those of thyroid, breast, prostate, and colorectal cancers have increased. Notably, thyroid cancer increased by 23.3% per year in both sexes, and became the most common cancer since 2009. The mortality for all cancers combined decreased by 2.7% per year from 2002 to 2011. Five-year relative survival rates of patients diagnosed in the last 5 years (2007-2011) have improved by 25.1% compared with those from 1993 to 1995. Conclusion Overall cancer mortality rates have declined since 2002 in Korea, while incidence has increased rapidly and survival has improved.

[1]  Hyunsoon Cho,et al.  Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2012 , 2015, Cancer research and treatment : official journal of Korean Cancer Association.

[2]  K. Jung,et al.  Cancer Statistics in Korea: Incidence, Mortality, Survival and Prevalence in 2010 , 2013, Cancer research and treatment : official journal of Korean Cancer Association.

[3]  S. Devesa,et al.  Rising Thyroid Cancer Incidence in the United States by Demographic and Tumor Characteristics, 1980-2005 , 2009, Cancer Epidemiology Biomarkers & Prevention.

[4]  Hai-rim Shin,et al.  Cancer Survival in Korea 1993-2002: A Population-Based Study , 2007, Journal of Korean medical science.

[5]  Hyejung Chang,et al.  Measuring the Burden of Disease in Korea , 2007, Journal of Korean medical science.

[6]  P. Dickman,et al.  Interpreting trends in cancer patient survival , 2006, Journal of internal medicine.

[7]  Louise Davies,et al.  Increasing incidence of thyroid cancer in the United States, 1973-2002. , 2006, JAMA.

[8]  P. Pisani,et al.  Nationwide cancer incidence in Korea, 1999~2001; first result using the national cancer incidence database. , 2005, Cancer research and treatment : official journal of Korean Cancer Association.

[9]  A. Oshima,et al.  [Index for evaluating completeness of registration in population-based cancer registries and estimation of registration rate at the Osaka Cancer Registry between 1966 and 1992 using this index]. , 1998, [Nihon koshu eisei zasshi] Japanese journal of public health.

[10]  J. Ferlay,et al.  Cancer Incidence in Five Continents , 1970, Union Internationale Contre Le Cancer / International Union against Cancer.

[11]  P. Trott,et al.  International Classification of Diseases for Oncology , 1977 .

[12]  K. Choi,et al.  Current status of thyroid cancer screening in Korea: results from a nationwide interview survey. , 2011, Asian Pacific journal of cancer prevention : APJCP.

[13]  F. Bray,et al.  Trends in cancer survival in 11 European populations from 1990 to 2009: a model-based analysis. , 2009, Annals of oncology : official journal of the European Society for Medical Oncology.

[14]  L. Sobin,et al.  International Classification of Diseases for Oncology, Third Edition , 2020, Definitions.

[15]  栗原 登,et al.  Trends cancer mortality for selected sites in 24 countries , 1960 .